Stock Ideas
New
StocksFundsScreenerSectorsWatchlists

Latest Cormorant Asset Management, LP Stock Portfolio

$2.09Billion

Equity Portfolio Value
Last Reported on: 14 Feb, 2024

About Cormorant Asset Management, LP and it’s 13F Hedge Fund Stock Holdings

Cormorant Asset Management, LP is a hedge fund based in Boston, MA. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $3.1 Billions. In it's latest 13F Holdings report, Cormorant Asset Management, LP reported an equity portfolio of $1.7 Billions as of 30 Sep, 2023.

The top stock holdings of Cormorant Asset Management, LP are MLTX, BBIO, . The fund has invested 27.1% of it's portfolio in MOONLAKE IMMUNOTHERAPEUTICS and 7.2% of portfolio in BRIDGEBIO PHARMA INC.

The fund managers got completely rid off PROTAGONIST THERAPEUTICS INC (PTGX), DESIGN THERAPEUTICS INC (DSGN) and 89BIO INC (ETNB) stocks. They significantly reduced their stock positions in ROCKET PHARMACEUTICALS INC (RCKT), ENLIVEN THERAPEUTICS INC and ZENTALIS PHARMACEUTICALS INC (ZNTL). Cormorant Asset Management, LP opened new stock positions in CRINETICS PHARMACEUTICALS IN (CRNX), RAYZEBIO INC and ALPINE IMMUNE SCIENCES INC (ALPN). The fund showed a lot of confidence in some stocks as they added substantially to IMMUNOVANT INC (IMVT), TARSUS PHARMACEUTICALS INC (TARS) and STRUCTURE THERAPEUTICS INC.

New Buys

Ticker$ Bought
AMBRX BIOPHARMA INC159,929,000
CARGO THERAPEUTICS INC27,376,300
SYNDAX PHARMACEUTICALS INC25,391,800
KORRO BIO INC25,363,100
ABIVAX SA22,791,000
SPYRE THERAPEUTICS INC20,166,000
NEUROGENE INC14,461,000
PRAXIS PRECISION MEDICINES I14,110,900

New stocks bought by Cormorant Asset Management, LP

Additions to existing portfolio by Cormorant Asset Management, LP

Reductions

Ticker% Reduced
APELLIS PHARMACEUTICALS INC-68.75
CYMABAY THERAPEUTICS INC-53.25
OLEMA PHARMACEUTICALS INC-45.46
DISC MEDICINE INC-44.44
RHYTHM PHARMACEUTICALS INC-35.29
BRIDGEBIO PHARMA INC-28.28
IDEAYA BIOSCIENCES INC-25.00
AEROVATE THERAPEUTICS INC-22.41

Cormorant Asset Management, LP reduced stake in above stock

Sold off

Ticker$ Sold
ERASCA INC-21,302,100
AMBRX BIOPHARMA INC-114,122,000
PRAXIS PRECISION MEDICINES I-16,245,000
CABALETTA BIO INC-43,824,800
AVIDITY BIOSCIENCES INC-11,242,300
ENLIVEN THERAPEUTICS INC-16,620,300
STRUCTURE THERAPEUTICS INC-53,262,300
COGENT BIOSCIENCES INC-9,750,000

Cormorant Asset Management, LP got rid off the above stocks

Current Stock Holdings of Cormorant Asset Management, LP

Last Reported on: 14 Feb, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
ACLXARCELLX INC4.511,700,00094,350,000REDUCED-20.93
AGLESPYRE THERAPEUTICS INC0.96937,08020,166,000NEW
ALPNALPINE IMMUNE SCIENCES INC2.322,550,00048,603,000ADDED34.21
ALXOALX ONCOLOGY HLDGS INC2.233,142,08046,785,600ADDED413
AMAMAMBRX BIOPHARMA INC7.6411,231,000159,929,000NEW
AMAMAMBRX BIOPHARMA INC0.000.000.00SOLD OFF-100
APLSAPELLIS PHARMACEUTICALS INC1.79625,00037,412,500REDUCED-68.75
AUTLAUTOLUS THERAPEUTICS PLC1.685,450,00035,098,000ADDED1,289
AVTEAEROVATE THERAPEUTICS INC1.311,211,70027,420,700REDUCED-22.41
AXNXAXONICS INC0.74250,00015,557,500UNCHANGED0.00
BBIOBRIDGEBIO PHARMA INC6.453,344,180135,005,000REDUCED-28.28
BCABBIOATLA INC0.141,181,1202,905,540UNCHANGED0.00
BMEABIOMEA FUSION INC2.483,570,87051,849,100UNCHANGED0.00
CABACABALETTA BIO INC0.000.000.00SOLD OFF-100
CBAYCYMABAY THERAPEUTICS INC2.031,800,00042,516,000REDUCED-53.25
CNTACENTESSA PHARMACEUTICALS PLC0.21561,6004,470,340UNCHANGED0.00
COGTCOGENT BIOSCIENCES INC0.000.000.00SOLD OFF-100
CRNXCRINETICS PHARMACEUTICALS IN1.951,150,00040,917,000ADDED4.36
ERASERASCA INC0.000.000.00SOLD OFF-100
EWTXEDGEWISE THERAPEUTICS INC1.332,551,99027,918,800REDUCED-13.4
EYPTEYEPOINT PHARMACEUTICALS INC6.666,038,240139,544,000ADDED88.69
GHRSGH RESEARCH PLC0.16593,0433,439,650UNCHANGED0.00
HARPHARPOON THERAPEUTICS INC1.082,349,06022,550,900ADDED4,245
IDYAIDEAYA BIOSCIENCES INC0.76450,00016,011,000REDUCED-25.00
IMRXIMMUNEERING CORP1.484,204,36030,902,100UNCHANGED0.00
IMVTIMMUNOVANT INC2.341,165,00049,081,400REDUCED-4.9
INSMINSMED INC0.85575,00017,819,200UNCHANGED0.00
KRTXKARUNA THERAPEUTICS INC0.000.000.00SOLD OFF-100
LBPHLONGBOARD PHARMACEUTICALS IN0.682,353,14014,189,400UNCHANGED0.00
LNTHLANTHEUS HLDGS INC0.2275,0004,650,000NEW
MLTXMOONLAKE IMMUNOTHERAPEUTICS24.508,494,150512,962,000ADDED4.32
MRNSMARINUS PHARMACEUTICALS INC1.693,250,00035,327,500ADDED23.81
OLMAOLEMA PHARMACEUTICALS INC1.652,456,80034,468,900REDUCED-45.46
ORTXORCHARD THERAPEUTICS PLC0.000.000.00SOLD OFF-100
PCVXVAXCYTE INC1.99665,00041,762,000UNCHANGED0.00
PHVSPHARVARIS N V2.291,711,46048,006,500ADDED25.71
PRAXPRAXIS PRECISION MEDICINES I0.67633,34514,110,900NEW
PRAXPRAXIS PRECISION MEDICINES I0.000.000.00SOLD OFF-100
RAPTRAPT THERAPEUTICS INC0.59496,75012,344,200ADDED52.85
RCKTROCKET PHARMACEUTICALS INC0.64450,00013,486,500UNCHANGED0.00
RNAAVIDITY BIOSCIENCES INC0.000.000.00SOLD OFF-100
RYTMRHYTHM PHARMACEUTICALS INC1.21550,00025,283,500REDUCED-35.29
SNDXSYNDAX PHARMACEUTICALS INC1.211,175,00025,391,800NEW
STOKSTOKE THERAPEUTICS INC0.271,087,8105,721,860UNCHANGED0.00
TARSTARSUS PHARMACEUTICALS INC2.152,221,42044,983,800REDUCED-15.26
VERVVERVE THERAPEUTICS INC0.23350,0004,879,000UNCHANGED0.00
VIGLVIGIL NEUROSCIENCE INC0.000.000.00SOLD OFF-100
VYNEVYNE THERAPEUTICS INC0.161,394,3403,248,800NEW
ZNTLZENTALIS PHARMACEUTICALS INC0.000.000.00SOLD OFF-100
RAYZEBIO INC3.601,213,48075,441,900ADDED2.64
CARGO THERAPEUTICS INC1.311,182,56027,376,300NEW
KORRO BIO INC1.21529,17025,363,100NEW
ABIVAX SA1.092,130,00022,791,000NEW
NEUROGENE INC0.69746,18014,461,000NEW
DISC MEDICINE INC0.34125,0007,220,000REDUCED-44.44
BIOHAVEN LTD0.1781,9633,508,020UNCHANGED0.00
NEUMORA THERAPEUTICS INC.0.0792,2931,573,600UNCHANGED0.00
STRUCTURE THERAPEUTICS INC0.000.000.00SOLD OFF-100
ENLIVEN THERAPEUTICS INC0.000.000.00SOLD OFF-100